Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW 1,980.00
-1.00 (-0.05%)
Jul 21, 2026, 3:30 PM KST
Aprogen Biologics Market Cap
Aprogen Biologics has a market cap or net worth of 26.08 billion as of July 21, 2026. Its market cap has decreased by -79.97% in one year.
Market Cap
26.08B
Enterprise Value
272.29B
Revenue
78.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,980.00
ChartMarket Cap Chart
Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 26.08B, an increase of 720.80%. That is a compound annual growth rate of 7.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 26.08B | -74.57% |
| Dec 30, 2025 | 102.54B | -21.60% |
| Dec 30, 2024 | 130.79B | -31.41% |
| Dec 28, 2023 | 190.68B | -4.89% |
| Dec 29, 2022 | 200.48B | -44.42% |
| Dec 30, 2021 | 360.71B | -31.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAMSUNG PHARM. Co., LTD. | 122.54B |
| AptaBio Therapeutics | 119.26B |
| HANDOK | 109.12B |
| Jeil Pharma Holdings | 104.54B |
| Enzychem Lifesciences | 76.86B |
| CKD Bio | 73.51B |
| Kukje Pharma | 71.07B |
| Ildong Holdings | 69.22B |